It is recorded that EGCG inhibits MAPKs including like ERK, jun n-terminal kinases (JNK), and p38 and helps numerous pathophysiological processes, involving cell proliferation, differentiation, and apoptosis in cancer cells (41). This evidence concerns the gene MAPK8 and cancer.